StockSelector.com
  Research, Select, & Monitor Sunday, July 15, 2018 3:16:49 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Juniper Pharmaceuticals, Inc.$11.40   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Juniper Pharmaceuticals, Inc. has an overall rank of 1981 out of 7006 stocks based on 10 positive rankings and 8 negative rankings.

Positive Rankings
Up EPS Surprise
Juniper Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
10 Day Gain
Juniper Pharmaceuticals rank is 99
Estimated Revenue Growth
Juniper Pharmaceuticals rank is 256
SSValue
The StockSelector Value for Juniper Pharmaceuticals is $26.84. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Juniper Pharmaceuticals is ranked 390.
Low vPut/Call
Juniper Pharmaceuticals has a low Put/Call ratio of 0.20 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Juniper Pharmaceuticals is ranked 414.
90 Day Gain
Juniper Pharmaceuticals rank is 491
Historic Revenue Growth
Juniper Pharmaceuticals rank is 974
Debt-to-Equity
Juniper Pharmaceuticals rank is 999
Highest Cash Growth
Juniper Pharmaceuticals rank is 1102
Highest Net Margin
Juniper Pharmaceuticals rank is 3307
Negative Rankings
High Put/Call
Juniper Pharmaceuticals has a high Put/Call ratio of 9.42 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Juniper Pharmaceuticals is ranked 44.
Overbought Stochastics
Juniper Pharmaceuticals rank is 110
Overbought RSI
The 14 Day Relative-Strength Index for Juniper Pharmaceuticals is 75.2. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Juniper Pharmaceuticals is ranked 120.
Negative Past Growth
Juniper Pharmaceuticals rank is 203
Negative ROE
Juniper Pharmaceuticals rank is 1300
Negative ROA
Juniper Pharmaceuticals rank is 1423
Price-to-Book
Juniper Pharmaceuticals rank is 1740
Price-to-Sales
Juniper Pharmaceuticals rank is 2206







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.